115 related articles for article (PubMed ID: 30612524)
1. CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma.
Li Y; Zhou X; Zhang Y; Yang J; Xu Y; Zhao Y; Wang X
Cell Cycle; 2019 Feb; 18(4):379-394. PubMed ID: 30612524
[TBL] [Abstract][Full Text] [Related]
2. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract][Full Text] [Related]
3. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
[TBL] [Abstract][Full Text] [Related]
4. Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways.
Li S; Fang J; Si T; Lu Y; Jiang L
Exp Hematol; 2021 Feb; 94():60-68.e2. PubMed ID: 33278489
[TBL] [Abstract][Full Text] [Related]
5. Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.
Cheng C; Wang T; Song Z; Peng L; Gao M; Hermine O; Rousseaux S; Khochbin S; Mi JQ; Wang J
Cancer Med; 2018 Feb; 7(2):380-396. PubMed ID: 29277967
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ENKD1 disrupts cellular homeostasis to promote lymphoma development.
Song T; He N; Hao Z; Yang Y
J Cell Physiol; 2023 Jun; 238(6):1308-1323. PubMed ID: 36960713
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA.
Dar AA; Sawada K; Dybas JM; Moser EK; Lewis EL; Park E; Fazelinia H; Spruce LA; Ding H; Seeholzer SH; Oliver PM
PLoS Biol; 2021 Feb; 19(2):e3001041. PubMed ID: 33524014
[TBL] [Abstract][Full Text] [Related]
8. Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma.
Liu B; Zhao X; Zhang S; Li Q; Li X; Huang D; Xia J; Ma N; Duan Y; Zhang X; Rao J
Leukemia; 2024 Feb; 38(2):351-364. PubMed ID: 38195819
[TBL] [Abstract][Full Text] [Related]
9. IL-1R8 expression in DLBCL regulates NK cell recruitment and influences patient prognosis.
Yu M; Zhang Q; Wan L; Wang S; Zou L; Chen Z; Li F
Funct Integr Genomics; 2023 Nov; 23(4):328. PubMed ID: 37907630
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2.
Yang H; Liu Y; Yang J; Zhang Q; Wang H; Chen Y; Zhou K
Biochem Biophys Res Commun; 2023 Oct; 676():21-29. PubMed ID: 37480689
[TBL] [Abstract][Full Text] [Related]
11. CUL4B mutations impair human cortical neurogenesis through PP2A-dependent inhibition of AKT and ERK.
Ma Y; Liu X; Zhou M; Sun W; Jiang B; Liu Q; Wang M; Zou Y; Liu Q; Gong Y; Sun G
Cell Death Dis; 2024 Feb; 15(2):121. PubMed ID: 38331954
[TBL] [Abstract][Full Text] [Related]
12. Expression of concern: The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. [Biomedicine & Pharmacotherapy 89 (2017) 939-948].
Biomed Pharmacother; 2022 Nov; 155():113857. PubMed ID: 36271537
[No Abstract] [Full Text] [Related]
13. CUL4B: trash talking at chromatin.
Green EM; Gozani O
Mol Cell; 2011 Aug; 43(3):321-3. PubMed ID: 21816341
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
15. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
[TBL] [Abstract][Full Text] [Related]
16. The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.
Liu X; Cui J; Gong L; Tian F; Shen Y; Chen L; Wang Y; Xia Y; Liu L; Ye X; Wang M; Liu G; Jiang B; Shao C; Zou Y; Gong Y
Oncogene; 2020 Apr; 39(17):3588-3603. PubMed ID: 32127645
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis.
Wu P; Hu H; Li J; Gong W
Onco Targets Ther; 2020; 13():1235-1243. PubMed ID: 32103991
[TBL] [Abstract][Full Text] [Related]
18. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.
Zhang H; Wang A; Tan Y; Wang S; Ma Q; Chen X; He Z
J Cell Mol Med; 2019 Oct; 23(10):6965-6977. PubMed ID: 31448526
[TBL] [Abstract][Full Text] [Related]
19. Abnormal level of CUL4B-mediated histone H2A ubiquitination causes disruptive HOX gene expression.
Lin Y; Yu J; Wu J; Wang S; Zhang T
Epigenetics Chromatin; 2019 Apr; 12(1):22. PubMed ID: 30992047
[TBL] [Abstract][Full Text] [Related]
20. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y; Yue D
Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
